Similar articles

• [C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor].

  Manavi M, Czerwenka KF, Zeillinger R, Speiser P, Kury F, Steinhart U, Peschke M, Kubista E, Reinold E. Manavi M, et al. Zentralbl Gynakol. 1992;114(2):82-5. Zentralbl Gynakol. 1992. PMID: 1350129 German.
• Luminal B breast tumors are not HER2 positive.

  Bhargava R, Dabbs DJ. Bhargava R, et al. Breast Cancer Res. 2008;10(5):404; author reply 405. doi: 10.1186/bcr2134. Epub 2008 Sep 26. Breast Cancer Res. 2008. PMID: 18831725 Free PMC article. No abstract available.
• Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.

  Rosser RJ. Rosser RJ. Cancer. 2003 Sep 1;98(5):1102-3; author reply 1103. doi: 10.1002/cncr.11596. Cancer. 2003. PMID: 12942582 No abstract available.
• Growth factor receptors and the progression of breast cancer.

  Kern FG, Cheville AL, Liu YL. Kern FG, et al. Semin Cancer Biol. 1990 Oct;1(5):317-28. Semin Cancer Biol. 1990. PMID: 1966491 Review.
• [Pathology and classification of malignant breast tumors].

  Bässler R. Bässler R. Z Arztl Fortbild (Jena). 1991 Oct 25;85(20):973-80. Z Arztl Fortbild (Jena). 1991. PMID: 1663676 Review. German. No abstract available.